Institutional Ownership Axsome Therapeutics, Inc. (AXSM)
This table provides information about the institutional ownership of Axsome Therapeutics, Inc. (AXSM). We have compiled data on the 403 institutions that hold shares in the stock, with a total of 37.3 Million shares, which have been reported (via 13F filing form) to have a value of $4.82 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Cannell & Co.
New York, NY |
Feb 05, 2024 Q4 2023 |
82,845
shares
|
$10.4 Million
0.22% of portfolio
|
Q4 2023
Reduced 20.49%
|
|
|
Eagle Asset Management Inc
St Petersburg, FL |
Nov 12, 2024 Q3 2024 |
82,791
shares
|
$10.4 Million
0.04% of portfolio
|
Q3 2024
Reduced 16.07%
|
|
|
Abrdn PLC
|
Jul 24, 2025 Q2 2025 |
81,916
shares
|
$10.3 Million
0.01% of portfolio
|
Q2 2025
Added 28.09%
|
|
|
Morgan Jess S & CO Inc
|
Oct 21, 2022 Q3 2022 |
78,895
shares
|
$9.92 Million
3.06% of portfolio
|
Q3 2022
Reduced 24.78%
|
|
|
Candriam S.C.A.
|
Aug 08, 2025 Q2 2025 |
76,727
shares
|
$9.64 Million
0.05% of portfolio
|
Q2 2025
Reduced 4.01%
|
|
|
Peregrine Capital Management LLC
|
Aug 01, 2025 Q2 2025 |
73,468
shares
|
$9.23 Million
0.25% of portfolio
|
Q2 2025
Added 23.02%
|
|
|
Act Capital Management, LLC
Wayne, PA |
Nov 03, 2022 Q3 2022 |
73,000
shares
|
$9.17 Million
4.5% of portfolio
|
Q3 2022
New holding
|
|
|
Canada Pension Plan Investment Board
Toronto Ontario, A6 |
Aug 14, 2025 Q2 2025 |
72,300
shares
|
$9.09 Million
0.01% of portfolio
|
Q2 2025
Added 62.47%
|
|
|
Neuberger Berman Group LLC
New York, NY |
Aug 25, 2025 Q2 2025 |
70,632
shares
|
$8.88 Million
0.01% of portfolio
|
Q2 2025
New holding
|
|
|
Ameriprise Financial Inc
Minneapolis, MN |
Aug 14, 2025 Q2 2025 |
70,084
shares
|
$8.81 Million
0.0% of portfolio
|
Q2 2025
Added 337.59%
|
|
|
Edgestream Partners, L.P.
Princeton, NJ |
Aug 13, 2025 Q2 2025 |
69,961
shares
|
$8.79 Million
0.21% of portfolio
|
Q2 2025
Reduced 0.18%
|
|
|
Spider Rock Advisors, LLC
|
Nov 01, 2024 Q3 2024 |
65,008
shares
|
$8.17 Million
0.09% of portfolio
|
Q3 2024
Reduced 7.14%
|
|
|
Ifp Advisors, Inc
|
Jul 24, 2025 Q2 2025 |
64,018
shares
|
$8.05 Million
0.2% of portfolio
|
Q2 2025
Reduced 6.01%
|
|
|
Emerald Mutual Fund Advisers Trust
|
Aug 04, 2025 Q2 2025 |
63,935
shares
|
$8.04 Million
0.45% of portfolio
|
Q2 2025
New holding
|
|
|
First Trust Advisors LP
Wheaton, IL |
Aug 13, 2025 Q2 2025 |
62,160
shares
|
$7.81 Million
0.01% of portfolio
|
Q2 2025
Added 114.71%
|
|
|
Rhumbline Advisers
Boston, MA |
Aug 12, 2025 Q2 2025 |
61,807
shares
|
$7.77 Million
0.01% of portfolio
|
Q2 2025
Added 12.87%
|
|
|
Moody Aldrich Partners LLC
|
Aug 04, 2025 Q2 2025 |
61,410
shares
|
$7.72 Million
1.39% of portfolio
|
Q2 2025
Reduced 1.49%
|
|
|
Swiss National Bank
Zurich, V8 |
May 12, 2025 Q1 2025 |
61,000
shares
|
$7.67 Million
0.01% of portfolio
|
Q1 2025
Reduced 0.65%
|
|
|
Capital Fund Management S.A.
Paris, I0 |
Aug 13, 2025 Q2 2025 |
60,763
shares
|
$7.64 Million
0.02% of portfolio
|
Q2 2025
Added 366.51%
|
|
|
Scout Investments, Inc.
|
Nov 12, 2024 Q3 2024 |
59,878
shares
|
$7.53 Million
0.16% of portfolio
|
Q3 2024
Reduced 13.92%
|
|
|
International Biotechnology Trust PLC
London, X0 |
Nov 14, 2023 Q3 2023 |
58,300
shares
|
$7.33 Million
1.38% of portfolio
|
Q2 2023
New holding
|
|
|
Marshall Wace, LLP
London, X0 |
Aug 13, 2025 Q2 2025 |
56,716
shares
|
$7.13 Million
0.01% of portfolio
|
Q2 2025
Reduced 17.44%
|
|
|
Federated Hermes, Inc.
Pittsburgh, PA |
Aug 13, 2025 Q2 2025 |
56,469
shares
|
$7.1 Million
0.01% of portfolio
|
Q2 2025
Added 117.27%
|
|
|
Clearbridge Investments, LLC
New York, NY |
Aug 12, 2025 Q2 2025 |
56,316
shares
|
$7.08 Million
0.0% of portfolio
|
Q2 2025
Reduced 17.38%
|
|
|
Bellevue Group Ag
Kuesnacht, V8 |
Aug 14, 2025 Q2 2025 |
56,253
shares
|
$7.07 Million
0.13% of portfolio
|
Q2 2025
Reduced 41.65%
|